Premium
Prognostic significance of myelodysplasia‐related changes according to the WHO classification among ELN ‐intermediate‐risk AML patients
Author(s) -
Devillier Raynier,
GelsiBoyer Véronique,
Murati Anne,
Prebet Thomas,
Rey Jérôme,
Etienne Anne,
D'Incan Evelyne,
Charbonnier Aude,
Blaise Didier,
Mozziconacci MarieJoëlle,
Vey Norbert
Publication year - 2015
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.23850
Subject(s) - medicine , cytarabine , myelodysplastic syndromes , cytogenetics , anthracycline , oncology , myeloid leukemia , international prognostic scoring system , leukemia , bone marrow , cancer , chromosome , breast cancer , biochemistry , chemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom